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EFFECT OF ALCOHOL CONSUMPTION ON
VARICEAL REBLEEDING AND MORTALITY
ABSTRACT
McCormick, P.A., Morgan, M.Y., Phillips, A., Yin, T.P., Mclntyre, N. and
Burroughs, A.K. (1992) The effects of alcohol use on rebleeding and mortality in
patients with alcoholic cirrhosis following oariceal haemorrhage. Journal of
Hepatology; 14, 99-103.
The effect of continued alcohol intake on prognosis in alcoholic cirrhotics who have
already bled from varices is controversial. To investigate the effect of alcohol intake
on prognosis we studied 189 consecutive alcoholic cirrhotics admitted, for the first
time, to the Royal Free Hospital with variceal bleeding. Sixty-six died within 30 days
of admission and 23 were excluded from the study for other reasons. Of the 100
remaining 15 remained ’probably abstinent’ over long-term follow-up, 29 drank
occasionally and 56 continued to misuse/abuse alcohol. The percentage survival
probability at 2 years was 66% in the probable abstainers, 68% in the occasional
drinkers and 63% in the alcohol abuse/misuse group. There were no significant
differences in either mortality or rebleeding rates between the three groups. A
rebleeding index (designed to take account of the number of rebleeds per patient and
the total length of follow-up) also failed to show any significant difference between
the three groups. The Cox proportional hazard model was used to study the effect of
the following factors on rebleeding and mortality; age, sex, alcohol use, Pugh’s
score, acute treatment received for initial variceal bleed and long-term treatment
received for prevention of recurrent variceal haemorrhage. Pugh’s score was
significantly related to risk of death during follow-up (p 0.0122), but none of the
others factors was significantly related to risk of rebleeding or mortality. Using
conventional methods to determine alcohol use we were unable to demonstrate
significant effects of alcohol intake on rebleeding or mortality in alcoholic cirrhotics
who had bled from oesophageal varices.138 HPB INTERNATIONAL
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The abstract cited above shows, somewhat surprisingly, that continued alcohol use/
abuse does not have a detrimental effect on survival or rebleeding rate following an
initial variceal bleed. Before telling our patients that continued drinking is not bad,
let us examine the evidence a little further.
The current paper has some unusual features which may limit the general
applicability of these data. First, the particular interest of this excellent Hepatology
group in the longterm management of patients with alcoholic liver disease may
have influenced their findings. Presumably, most of the patients in this study had
their first physician contact at the time of their initial bleed. What changed
thereafter? While the assessment of continued drinking in this study is probably as
good as can be achieved, the authors do not provide objective evidence of what
effect this had on the liver. Table 3 gives mixed messages, with good serum albumin
levels on one hand, and elevated bilirubin levels and ascites and encephalopathy in
half the patients on the other hand. This could be interpreted as indicating an
overall improvement in nutritional status despite ongoing active liver disease. Was
nutrition emphasized as an important treatment factor at follow-up? And, if so,
might such recommendations account for their findings? Objective evidence of the
presence of alcoholic hepatitis at initial presentation or during subsequent follow-
up would provide more persuasive evidence that continued alcoholic use played
some role in the end-points evaluated.
A second unusual feature of this study is the lack of definitive management for
variceal bleeding in 75% of patients. From the point of view of this study, this does
indeed permit assessment of the effect of continued drinking on rebleeding and
survival in the untreated patient. As discussed below, this may be different to the
effect of continued drinking on patients who have received definitive therapy. The
rebleeding rates of 50% and 70% at one and two years reaffirm old data1, and
redefine the need to institute some therapy to reduce the risk of recurrent variceal
bleeding after an initial bleed. While many of the deaths in the reported study were
"liver related", the authors have not defined how many could be directly attributed
to rebleeding.
Where do these data fit relative to other studies? The authors address the lack of
data on this topic in the literature, and highlight for the reader the difficulty in
collecting such data. Their findings are consistent with the only other study which
has directly addressed this question2. What effect does continued alcohol misuse
have on outcome after more definitive therapy? In our own particular population of
interest, patients receiving distal splenorenal shunt for prevention of recurrent
variceal bleeding, the alcohol patient does behave differently. Poorer survival3’4,
and increased loss of portal perfusion to the liver4’5, have been shown in this
population compared to patients with nonalcoholic cirrhosis. An association
between loss of portal flow and active alcoholism has been documented6, and is
supported by improved outcome in patients with prolonged hospitalization prior to
surgery, which is presumably associated with improved liver status7. As always, the
questions remain open as to how good is the documentation of alcohol abstinence,
consumption and how far continued drinking accounts for these findings.HPB INTERNATIONAL 139
In the Emory prospective randomized trial comparing endoscopic sclerotherapy
to distal splenorenal shunt8, it was again the patients with alcoholic liver disease
who behaved very differently with the two therapies. Improved survival in patients
randomized to sclerotherapy (one third of whom required surgical rescue), was
only seen in patients with alcoholic cirrhosis (p < .01), and was associated with an
initial improvement in quantitative liver function. The increased mortality from
liver failure associated with return to drinking in the distal shunt patients in this
study, raised the question as to whether the liver is more susceptible to injury from
alcohol after such an operative procedure. An argument can certainly be built for
altered metabolism, but remains unproven.
We must acknowledge that there are still many interactions of alcohol with the
liver which we do not understand. The present data do, however, help clarify two
things: first, the risk of rebleeding after an initial variceal bleed is not related to the
amount of alcohol consumed, and second, that once an alcoholic has bled from
varices it is factors other than alcohol consumption which determine survival when
no other definitive therapy is instituted. With definitive therapy such as distal
splenorenal shunt, continued alcohol abuse is associated with increased mortality.
Patients... we should continue to advise abstinence.
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